A new Zofran birth defects lawsuit filed against drug manufacturer GlaxoSmithKline alleges that a child was born with only one kidney after being exposed to Zofran in the uterus. The child’s parents allege that GSK failed to properly warn them about the risks of birth defects associated with Zofran use.
The child was born with only one functioning kidney and not enough connective tissues necessary for a transplant. He was also missing a fully functioning deferens, which could greatly reduce the likelihood of the child reproducing when he grows up. The child’s mother was given the anti-nausea drug Zofran to combat morning sickness during the first trimester of her pregnancy.
Although Zofran has only been approved for use in post-surgery and cancer patient, thousands of pregnant women are given the drug to combat common side effects of early pregnancy, including nausea and vomiting. Several recent studies have linked Zofran to an increased risk of morning sickness drug side effects, including cleft palate defects, heart defects and premature birth.